A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii
dc.contributor.author | Mohamed, Mohamed F. | en |
dc.contributor.author | Brezden, Anna | en |
dc.contributor.author | Mohammad, Haroon | en |
dc.contributor.author | Chmielewski, Jean | en |
dc.contributor.author | Seleem, Mohamed N. | en |
dc.date.accessioned | 2020-09-21T16:08:06Z | en |
dc.date.available | 2020-09-21T16:08:06Z | en |
dc.date.issued | 2017-07-31 | en |
dc.date.updated | 2020-09-21T16:08:00Z | en |
dc.description.abstract | Antimicrobial peptides (AMPs) represent a promising therapeutic alternative for the treatment of antibiotic-resistant bacterial infections. The present study investigates the antimicrobial activity of new, rationally-designed derivatives of a short α-helical peptide, RR. From the peptides designed, RR4 and its D-enantiomer, D-RR4, emerged as the most potent analogues with a more than 32-fold improvement in antimicrobial activity observed against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii. Remarkably, D-RR4 demonstrated potent activity against colistin-resistant strains of P. aeruginosa (isolated from cystic fibrosis patients) indicating a potential therapeutic advantage of this peptide over several AMPs. In contrast to many natural AMPs, D-RR4 retained its activity under challenging physiological conditions (high salts, serum, and acidic pH). Furthermore, D-RR4 was more capable of disrupting P. aeruginosa and A. baumannii biofilms when compared to conventional antibiotics. Of note, D-RR4 was able to bind to lipopolysaccharide to reduce the endotoxin-induced proinflammatory cytokine response in macrophages. Finally, D-RR4 protected Caenorhabditis elegans from lethal infections of P. aeruginosa and A. baumannii and enhanced the activity of colistin in vivo against colistin-resistant P. aeruginosa. | en |
dc.description.version | Published version | en |
dc.format.extent | 13 page(s) | en |
dc.format.medium | Electronic | en |
dc.format.mimetype | application/pdf | en |
dc.identifier | ARTN 6953 (Article number) | en |
dc.identifier.doi | https://doi.org/10.1038/s41598-017-07440-0 | en |
dc.identifier.eissn | 2045-2322 | en |
dc.identifier.issn | 2045-2322 | en |
dc.identifier.issue | 1 | en |
dc.identifier.orcid | Seleem, Mohamed [0000-0003-0939-0458] | en |
dc.identifier.other | 10.1038/s41598-017-07440-0 (PII) | en |
dc.identifier.pmid | 28761101 (pubmed) | en |
dc.identifier.uri | http://hdl.handle.net/10919/100014 | en |
dc.identifier.volume | 7 | en |
dc.language.iso | en | en |
dc.publisher | Nature Publishing Group | en |
dc.rights | Creative Commons Attribution 4.0 International | en |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | en |
dc.subject | INTRACELLULAR PATHOGENIC BACTERIA | en |
dc.subject | CYSTIC-FIBROSIS PATIENTS | en |
dc.subject | HOST-DEFENSE PEPTIDES | en |
dc.subject | IN-VIVO | en |
dc.subject | ANTIBACTERIAL ACTIVITY | en |
dc.subject | INFECTION MODEL | en |
dc.subject | PLAUSIBLE MODE | en |
dc.subject | HUMAN SERUM | en |
dc.subject | IDENTIFICATION | en |
dc.subject | MECHANISM | en |
dc.subject.mesh | Animals | en |
dc.subject.mesh | Humans | en |
dc.subject.mesh | Caenorhabditis elegans | en |
dc.subject.mesh | Biofilms | en |
dc.subject.mesh | Acinetobacter baumannii | en |
dc.subject.mesh | Pseudomonas aeruginosa | en |
dc.subject.mesh | Pseudomonas Infections | en |
dc.subject.mesh | Cystic Fibrosis | en |
dc.subject.mesh | Colistin | en |
dc.subject.mesh | Antimicrobial Cationic Peptides | en |
dc.subject.mesh | Microbial Sensitivity Tests | en |
dc.subject.mesh | Drug Stability | en |
dc.subject.mesh | Drug Resistance, Multiple, Bacterial | en |
dc.subject.mesh | Drug Design | en |
dc.title | A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii | en |
dc.title.serial | Scientific Reports | en |
dc.type | Article - Refereed | en |
dc.type.dcmitype | Text | en |
dc.type.other | Article | en |
dc.type.other | Journal | en |
dcterms.dateAccepted | 2017-06-28 | en |
pubs.organisational-group | /Virginia Tech/Veterinary Medicine | en |
pubs.organisational-group | /Virginia Tech/Faculty of Health Sciences | en |
pubs.organisational-group | /Virginia Tech/All T&R Faculty | en |
pubs.organisational-group | /Virginia Tech/Veterinary Medicine/Biomedical Sciences and Pathobiology | en |
pubs.organisational-group | /Virginia Tech/Veterinary Medicine/CVM T&R Faculty | en |
pubs.organisational-group | /Virginia Tech | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resista.pdf
- Size:
- 2.4 MB
- Format:
- Adobe Portable Document Format